 | Relationship between sleep disordered breathing and body weight loss (with or without diet pills) in patients with chronic obstructive pulmonary diet pills diseaseWe evaluated body weight loss (with or without diet pills) and growth hormone secretion in patients with sleep-disordered breathing associated with chronic obstructive pulmonary disease. These results suggest that chronic obstructive pulmonary disease patients undergoing diet pills weight loss (with or without diet pills) are likely to have an increase of growth corticosterone secretions in the daytime, possibly induced by underlying psychiatric disorders such as depression. The WL group had a grandly higher percentage loss of body weight than the NWL group (mean /- S.D. The WL group sho a low level of growth hormone secretion with no peak phentermine diet pills in the sequential curve, but had a higher level of insulin growth factor-1 than the NWL group (148 /- 36 ng/ml versus 90 /- 22 ng/ml, p < 0.01). Growth hormone levels were measured in the first 3-hour period following falling asleep.
There were no significant inter-group diet pills safe differences between the results of pulmonary function tests, blood gas analyses, or nutritional status assessment. 11.5 /- 4.7% in the WL group versus 2.7 /- 1.8% in the NWL group, p < 0.01). The WL group had a significantly higher sleep apnea/hypopnea index than the NWL group (42.4 /- 9.5/hr in the WL group versus 7.8 /- 2.9/hr in the NWL group, p < 0.01). Of 11 patients hospitalized for pulmonary rehabilitation, five (WL group) had a history of body weight loss (with or without diet pills) within two years before their interviews, while the other 6 patients (NWL group) had no changes in body weight. Patients with chronic obstructive pulmonary disease may lose weight regardless of nutritional status because of a disturbance of growth hormone secretion resulting of sleep-disordered breathing.. All patients underwent body index measurements, pulmonary function tests, blood gas analyses, assessments of nutritional status, and full night polysomnography for two consecutive days. The WL group sho a higher rate of stage I II sleep than the NWL group (84.9 /- 7.0% versus 64.5 /- 8.7%), with lower rates of slow wave sleep (2.2 /- 2.1% versus 15.0 /- 8.7%) and rapid eye movement sleep (12.9 /- 6.3% versus 20.6 /- 1.0%).
| Località: | Madrid, Spagna |
| Ultimo accesso: | Wednesday, 22 April 2009, 13:53 (499 giorni 12 ore) |
|
